Peptonic Medical receives order from Orion Pharma worth over one million SEK
Stockholm 3rd October 2018 - Peptonic Medical AB (publ) (’Peptonic’) or (’Company’) today announced that it has received a launch order for the Finnish version of VagiVital® from Orion Pharma. The value of the order is in excess of one million SEK, and it shall be delivered by the end of this year. - This is another historical event in Peptonic. That Orion Pharma has decided to launch Peptonic’s non-prescription product for the treatment of vaginal dryness is an accolade to the clinical documentation and quality of the product, says Johan Inborr, CEO of Peptonic Medical. Soon